Ausgabe 1/2022
Inhalt (21 Artikel)
Re-Evaluating Limitations in Atopic Dermatitis Meta-Analysis Is Important in Interpreting its Results
Efstratios Vakirlis, Aikaterini Tsentemeidou, Stamatios Gregoriou
Arthritis Interception in Patients with Psoriasis Treated with Guselkumab
Alen Zabotti, Ivan Giovannini, Dennis McGonagle, Salvatore De Vita, Giuseppe Stinco, Enzo Errichetti
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
Andrew Blauvelt, Marjolein de Bruin-Weller, Eric L. Simpson, Zhen Chen, Marius Ardeleanu, Ana B. Rossi
Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review
Maria-Magdalena Balp, Anna C. Halliday, Thomas Severin, Saoirse A. Leonard, Gautam Partha, Manik Kalra, Alexander M. Marsland
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
Amy C. M. Musiek, Kerri E. Rieger, Martine Bagot, Jennifer N. Choi, David C. Fisher, Joan Guitart, Paul L. Haun, Steven M. Horwitz, Auris Onn-Lay Huen, Bernice Y. Kwong, Mario E. Lacouture, Sarah J. Noor, Alain H. Rook, Lucia Seminario-Vidal, Maarten H. Vermeer, Youn H. Kim
Microneedling and Its Use in Hair Loss Disorders: A Systematic Review
Robert S. English Jr., Sophia Ruiz, Pedro DoAmaral
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey
Mark Lebwohl, Richard G. Langley, Carle Paul, Lluis Puíg, Kristian Reich, Peter van de Kerkhof, Hsiuan-Lin Wu, Sven Richter, Shauna Jardon, Paolo Gisondi
Correction to: Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey
Mark Lebwohl, Richard G. Langley, Carle Paul, Lluis Puíg, Kristian Reich, Peter van de Kerkhof, Hsiuan-Lin Wu, Sven Richter, Shauna Jardon, Paolo Gisondi
Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study
Toni Maria Klein, Christine Blome, C. Elise Kleyn, Curdin Conrad, Paul G. Sator, Mona Ståhle, Kilian Eyerich, Marc Alexander Radtke, Christine Bundy, Myriam Cordey, Christopher E. M. Griffiths, Matthias Augustin
Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry
Jessica A. Walsh, Kristina Callis Duffin, Abby S. Van Voorhees, Soumya D. Chakravarty, Timothy Fitzgerald, Amanda Teeple, Katelyn Rowland, Jonathan Uy, Robert R. McLean, Wendi Malley, Angel Cronin, Joseph F. Merola
Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: Effect of Demographics and Baseline Disease Characteristics on Efficacy
Shinichi Imafuku, Yayoi Tada, Yoshinori Umezawa, Shinya Sakurai, Naoki Hoshii, Hidemi Nakagawa
Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16
Jonathan I. Silverberg, Mark Boguniewicz, Jill Waibel, Jamie Weisman, Lindsay Strowd, Luna Sun, Yuxin Ding, Meghan Feely, Fabio P. Nunes, Eric L. Simpson
Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
Kathleen W. Wyrwich, Randall Winnette, Randall Bender, Kavita Gandhi, Nicole Williams, Nimanee Harris, Lauren Nelson
Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis
April W. Armstrong, Ahmed M. Soliman, Keith A. Betts, Yan Wang, Yawen Gao, Vassilis Stakias, Luis Puig
Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis
Howard Thom, Vincent Cheng, Edna Keeney, Maureen P. Neary, Anthony Eccleston, Chuanbo Zang, Joseph C. Cappelleri, Amy Cha, Jacob P. Thyssen
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment
April Armstrong, Andrew Blauvelt, Eric L. Simpson, Catherine H. Smith, Pedro Herranz, Yoko Kataoka, Seong Jun Seo, Silvia M. Ferrucci, Jingdong Chao, Zhen Chen, Ana B. Rossi, Brad Shumel, Paul Tomondy
Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO
Kristian Reich, Bernhard Korge, Nina Magnolo, Maria Manasterski, Uwe Schwichtenberg, Petra Staubach-Renz, Stephan Kaiser, Josefine Roemmler-Zehrer, Natalie Núnez Gómez, Katrin Lorenz-Baath
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks
Andrew Blauvelt, Marjolein de Bruin-Weller, Eric L. Simpson, Zhen Chen, Annie Zhang, Brad Shumel
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis
Curdin Conrad, Christine-Elke Ortmann, Marc Vandemeulebroecke, Torben Kasparek, Kristian Reich
Clinical Utility of Silk-Elastin Sponge in Patients with Chronic and Acute Skin Ulcers: Study Protocol of a Multicenter Clinical Trial
Kazuo Noda, Yasuhiro Katayama, Eiichi Sawaragi, Michiharu Sakamoto, Hiroki Yamanaka, Itaru Tsuge, Motoki Katsube, Naoki Morimoto
Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology
Kim A. Papp, Melinda J. Gooderham, Charles W. Lynde, Yves Poulin, Jennifer Beecker, Jan P. Dutz, Chih-ho Hong, Robert Gniadecki, Mark G. Kirchhof, Catherine Maari, Ronald B. Vender